APIs para pesquisa e impurezas

Applications Labelled 5-FU, a potent antineoplastic agent in clinical use. Also an inhibitor of DNA synthesis. Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package References Rudy, B.C., et al.: Anal. Profiles Drug Subs., 2, 221 (1973), Miyashita, O., et al.: Chem. Pharm. Bull., 29, 3181 (1981), Hansen, R.M., et al.: Cancer Invest., 9, 637 (1991),

Applications Labelled Indapamide. Used as an antihypertensive. Diuretic. References Leary, et al.: Curr. Ther. Res., 15, 571 (1973), Kyncl, J., et al.: Arzneim.-Forsch., 25, 1491 (1975), DiFeo, T.J., et al.: Anal. Profiles Drug Subs. Excip., 23, 229 (1994),

Please enquire for more information about (E)-N,N-Didesmethyl-4-hydroxy tamoxifen including the price, delivery time and more detailed product information at the technical inquiry form on this page

Please enquire for more information about BET-IN-4 including the price, delivery time and more detailed product information at the technical inquiry form on this page

3-Hydroxy deoxy dihydro artemisinin is a drug product that is an analytical standard for the determination of artemisinin in natural and synthetic samples. It is a metabolite of artemisinin, which is a natural compound extracted from Artemisia annua L. (Asteraceae). 3-Hydroxy deoxy dihydro artemisinin is also an impurity found in commercial preparations of artemisinins. 3-Hydroxy deoxy dihydroartemisinin has been used as an API impurity standard, and has been synthesized as part of drug development research and development. The purity of this substance was determined by HPLC analysis, and it complies with the pharmacopoeia requirements.

Azilsartan cyano-des-1,2,4-oxadiazol-5-ol ketone is a compound used in various industrial applications. It is commonly used as an impurity reference standard for quality control purposes. Azilsartan cyano-des-1,2,4-oxadiazol-5-ol ketone has been found to be stable in xylose and methanol solutions and does not show any significant degradation or interaction with these substances. Additionally, it has been observed that Azilsartan cyano-des-1,2,4-oxadiazol-5-ol ketone does not react with glutamate or chamomile extract. Furthermore, Azilsartan cyano-des-1,2,4-oxadiazol-5-ol ketone does not exhibit any interactions with basic proteins or fatty acids. It has also been tested for compatibility with other commonly used pharmaceutical compounds such as ticagrelor, toc

Applications Labelled synthetic mu-opioid agonist. This is a controlled substance (opiate). References James, M.K., et al.: J. Pharmacol. Exp. Ther., 259, 712 (1991), Hoffman, W.E., et al.: Anesthesiology, 79, 107 (1993), Selinger, K., et al.: J. Pharm. Biomed. Anal., 12, 243 (1994), Richardson, T.D., et al.: Expert Opin. Drug Saf., 4, 643 (2005),

6,7-Dimethoxy-2-[4-[(tetrahydro-2-furanyl)carbonyl]-1-piperazinyl]-4(3H)-quinazolinone is a drug product. It is an analytical standard for the impurity of CAS No. 1177261-73-2. This compound has been synthesized by custom synthesis and its purity is high. The compound has been used in research and development of drugs, pharmacopoeia, HPLC standards, and other related fields.

Please enquire for more information about (S)-Aspartimide including the price, delivery time and more detailed product information at the technical inquiry form on this page

Compounds with other nitrogen function, nesoi

Acid red 119 is an anticancer agent that has been shown to inhibit the growth of human and Chinese cancer cells. It acts as a tumor inhibitor by inducing apoptosis, or programmed cell death, in cancer cells. Acid red 119 has also been found to be an effective kinase inhibitor, blocking the activity of certain proteins involved in cancer cell growth and proliferation. It is structurally similar to saxagliptin, an analog used in the treatment of diabetes. Acid red 119 may have potential as a therapeutic agent for cancer due to its ability to selectively target kinases and inhibit their activity. Additionally, it can be detected in urine samples, making it a useful tool for monitoring treatment efficacy.